It can lead to weight loss, better glycemic control, and reduced cardiometabolic risk factors
The results of this relatively small study suggest that exercise may be an important component to minimize weight regain after GLP-1 receptor agonist discontinuation
Consider consulting a registered dietitian for personalized guidance, especially if you have kidney disease or other conditions requiring dietary modifications
Beware of counterfeit products, as they may cause serious adverse reactions Important safety considerations Patients taking retatrutide often experience common gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, and stomach pain
Maybe youve been told its allergies, IBS, or just inflammation, but it never fully explains your symptoms
The study "Liraglutide versus placebo as an adjunct to glucose-lowering therapy in patients with type 2 diabetes and moderate renal failure" (LIRA-RENAL) did not demonstrate a benefit of liraglutide in lowering eGFR, although the duration of the study (26 weeks) may have been insufficient to show an effect